Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesInjection and Intravenous Infusion Chemotherapy and Other Highly Complex Drug or Highly Complex Biologic Agent AdministrationCPT cpt-96401-subcutaneous-intramuscular-chemotherapy-administration
    Ask Trek AI about this page

    CPT 96401: Subcutaneous or Intramuscular Nonhormonal Chemotherapy

    Medicare pays $75 and commercial payers pay $129 on average nationally for this procedure.

    CPT code 96401 describes administration of nonhormonal antineoplastic chemotherapy agents by subcutaneous or intramuscular injection; this is a chemotherapy administration service provided in outpatient clinic settings or other ambulatory care locations where injectable oncology therapy is delivered, and is used for coding clinician time and procedure when drugs are given via SC or IM routes.

    For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.

    Customize your policy alerts

    Sign up for cpt 96401 policy alerts

    Get alerted when payer policies referencing 96401 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    National Reimbursement Benchmarks

    Commercial averages sit well above Medicare for CPT 96401: Blue Cross Blue Shield, Aetna, Cigna, UnitedHealth Group and BUCA have mean rates clustered in the $115–$135 range, while Medicare’s mean is $74.9, creating a commercial-to-Medicare gap of roughly $40–$60. Notably, BUCA’s mean of $129.4 aligns with the higher end of commercial payers, exceeding Medicare by about $54.5.

    Dispersion varies materially across payers. Calculating interquartile ranges (P75−P25) yields the tightest spread for UnitedHealth Group at $66.4 and the widest for Aetna at $79.0. Blue Cross Blue Shield shows a relatively narrow IQR of $63.5, Cigna an IQR of $78.0, and BUCA an IQR of $68.4. These differences indicate more consistent commercial payment levels for some payers versus greater variability for others.

    Table of contents

    Progress1 / 8

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools
    National Payer Mean Reimbursement Rates

    State Reimbursement Rates

    State: Alaska1 / 51

    Rate by payer

    Clinical & Coding Specifications

    Clinical Context

    A 63-year-old patient with a history of multiple myeloma presents to the oncology clinic for scheduled administration of a nonhormonal antineoplastic agent given by subcutaneous injection. The patient’s current diagnosis is C90.02 (multiple myeloma, in relapse) after laboratory evidence of rising monoclonal protein and symptomatic bone pain. The clinic visit includes pre-administration assessment (vital signs, review of recent labs including complete blood count and chemistry panel), verification of the chemotherapy order and consent, and preparation of the subcutaneous medication by pharmacy. The oncology nurse performs site selection, skin preparation, and delivers the subcutaneous injection while monitoring for immediate adverse reactions. Post-injection observation of the patient occurs for a short period to assess tolerance and manage potential injection-site reactions or acute hypersensitivity. Documentation includes the drug name and dose, route subcutaneous or intramuscular, lot number, administration time, patient tolerance, and any immediate interventions. Billing for this service uses 96401 for nonhormonal antineoplastic chemotherapy administered subcutaneously or intramuscularly, linked to the appropriate ICD-10 diagnosis such as C90.02, with additional codes recorded for any concurrent evaluation or procedures as applicable.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure

    Related Modifiers

    8 rows

    ModifierDescriptionWhen to Use
    25CPT modifier 25 indicates that on the same day as another procedure or service, the same physician or other qualified health care professional provided a significant, separately identifiable…- When to apply: Use modifier 25 only on an E/M code to indicate the same provider delivered a significant, separately identifiable E/M service on the same day as another procedure or service — i.e.,…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    76Modifier -76, Repeat Procedure or Service by Same Physician or Other Qualified Health Care Professional, is appended when the same provider performs an identical, medically necessary procedure or…- Use modifier -76 when the same physician or other qualified health care professional performs an identical procedure or service a second (or subsequent) time on the same date of service and the…
    77Modifier 77 indicates that a previously performed procedure or service was legitimately repeated by a different physician or other qualified health care professional. The AMA’s CPT definition…- Use modifier 77 when a basic procedure or service already performed is repeated by a different physician or other qualified health care professional (for example, a second provider independently…
    50Modifier –50 (Bilateral Procedure) is appended to a CPT code when an identical procedure is performed on paired anatomical structures during the same operative session. The AMA states to add…- Use modifier -50 when the same CPT surgical, diagnostic, or radiology procedure is performed on paired anatomical structures (both sides of the body) during the same operative/session by the same…
    51Modifier –51 (Multiple Procedures) is used when the same provider performs multiple procedures in the same session to identify secondary, non‑exempt procedures and indicate payment reduction logic…- Use modifier -51 when the same provider performs multiple distinct procedures during the same patient encounter: report the highest‑valued procedure first (no modifier) and append -51 to…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207RH0003X
    207RX0202X
    207ZP0102X
    207VC0300X
    171W00000X
    1835S0206X
    2472E0500X
    222Q00000X

    Related Payer Policy Updates

    Specialty: Hematology/Oncology1 / 3

    10 rows

    PolicyPayerEffective Date
    Bendamustine Products Coverage Criteriablue cross blue shield - tennessee2027-01-30
    T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and RomidepsinMass General Brigham Health Plan2027-01-04
    Brentuximab Vedotin (Adcetris®) Coverage Criteriablue cross blue shield - tennessee2026-12-31
    Pemetrexed Coverageblue cross blue shield - tennessee2026-12-31
    Tumor Treatment Fields - Medical PolicyHealth-New-England2026-12-01
    Extracorporeal PhotopheresisCigna2026-11-15
    Hematology - AphexdaCigna2026-11-15
    VonvendiCigna2026-11-15
    Extracorporeal PhotopheresisCigna2026-11-15
    Yartemlea (narsoplimab-wuug) Coverage for TA-TMANeighborhood Health Plan of Rhode Island2026-11-01

    Related Codes

    CPT-96402-SUBCUTANEOUS-INTRAMUSCULAR-HORMONAL-ANTINEOPLASTIC-ADMINISTRATION

    CPT 96402: Subcutaneous/Intramuscular Hormonal Anti‑Neoplastic Administration

    CPT-96405-INTRALESIONAL-CHEMOTHERAPY-ONE-TO-SEVEN-LESIONS

    CPT 96405: Intralesional Chemotherapy, 1–7 Lesions

    CPT-96406-INTRALESIONAL-CHEMOTHERAPY-MORE-THAN-7-LESIONS

    CPT 96406: Intralesional Chemotherapy for >7 Lesions

    CPT-96409-INTRAVENOUS-PUSH-CHEMOTHERAPY-INITIAL-DRUG

    CPT 96409: Intravenous Push Chemotherapy, Single/Initial Drug

    CPT-96411-ADD-ON-INTRAVENOUS-PUSH-CHEMOTHERAPY-DRUG

    CPT 96411: Add-On IV Push for Additional Chemotherapy Drug

    CPT-96413-INTRAVENOUS-CHEMOTHERAPY-INFUSION-INITIAL-HOUR

    CPT 96413: Intravenous Chemotherapy Infusion, Initial Hour

    CPT-96415-ADDITIONAL-HOUR-CHEMOTHERAPY-INTRAVENOUS-INFUSION

    CPT 96415: Continued Intravenous Chemotherapy Infusion, Per Additional Hour

    CPT-96416-CHEMOTHERAPY-INITIATION-PORTABLE-IMPLANTABLE-PUMP

    CPT 96416: Initiation of Intravenous Chemotherapy via Pump

    CPT-96417-ADD-ON-IV-CHEMOTHERAPY-INFUSION-DIFFERENT-AGENT

    CPT 96417: Continued Intravenous Chemotherapy Administration

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    96402Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplasticAlternative code for hormonal antineoplastic agents given via the same routes; distinguishes drug class from 96401.
    96372Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscularNon-chemotherapy injection code used for therapeutic injections that are not antineoplastic; used when chemotherapy-specific coding is not applicable.
    96409Chemotherapy administration; intravenous, push techniqueRelated for cases where therapy is given IV push instead of subcutaneous/intramuscular; represents a different route and technique in the workflow.
    96413Chemotherapy administration; intravenous infusion, up to 1 hourRelated when nonhormonal antineoplastic therapy is administered by IV infusion rather than subcutaneously or intramuscularly; represents longer infusion services.